Cyclosporine and COVID-19: Risk or favorable?

Poulsen, Nadia Nicholine; von Brunn, Albrecht; Hornum, Mads; Blomberg Jensen, Martin

Poulsen, Nadia Nicholine; von Brunn, Albrecht; Hornum, Mads; Blomberg Jensen, Martin.

Afiliação

Poulsen NN; Department of Growth and Reproduction, Group of Skeletal, Mineral, and Gonadal Endocrinology, Rigshospitalet, Copenhagen, Denmark.
von Brunn A; Max von Pettenkofer-Institute, Ludwig-Maximilians-University Munich/German Center for Infection Research (DZIF), Munich, Germany.
Hornum M; Department of Nephrology, Rigshospitalet, Copenhagen, Denmark.
Blomberg Jensen M; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.

Am J Transplant ; 20(11): 2975-2982, 2020 11.

Article em En | MEDLINE | ID: mdl-32777170

Assuntos

Tratamento Farmacológico da COVID-19; Ciclosporina/uso terapêutico; Hospedeiro Imunocomprometido; Pandemias; SARS-CoV-2; COVID-19/epidemiologia; COVID-19/imunologia; Humanos; Imunossupressores/uso terapêutico

Palavras-chave

clinical research/practice; immunosuppressant - calcineurin inhibitor (CNI); immunosuppression/immune modulation; infection and infectious agents - viral; infectious disease; organ transplantation in general

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google